CEACAM5 and pancreatic adenocarcinoma: Expression of CEA on human pancreas cancer specimens was evaluated by performing IHC utilizing the anti-CEA scFv-Fc (H310A) antibody fragment upon a tissue microarray containing 107 1-mm-tissue cores of pancreatic adenocarcinomas.